Abstract
Background: Gestational diabetes (GDM) is a pregnancy-related endocrinopathy. Its etiology is not well understood. Obesity and insulin resistance coexist in GDM. Apelin is an adipocytokine secreted by fatty cells and expressed in many organs; it can modulate blood glucose. According to research, apelin levels are higher in obese and type 2 diabetes patients. We aimed to examine the value of serum apelin as a reliable marker for GDM at 24-28 weeks of pregnancy.
Methods: A case-control study recruited 120 pregnant women in an age range of 20-40 years with a singleton pregnancy at 24-28 weeks of pregnancy; all were matched in BMI and gestational age. They are divided into 2 groups: 60/120 GDM cases based on the International Association of Diabetes and Pregnancy and 60/120 matched controls at a gestational age of 24-28 weeks at Al-Yarmouk Teaching Hospital. Demographics data, serum biochemical permeates including HbA1c, fasting blood sugar (FBS), fasting insulin level, 1 h plasma glucose, and 2 h plasma glucose, following a 75-gram glucose loading, and a fasting insulin level were recorded.
Results: None of the demographic criteria were significant between the two groups at P < 0.05. FBS, fasting insulin, OGTT-1 and 2 hours, HbA1c, and serum apelin were significantly higher in GDM cases with P < 0.0001. Pearson's correlations show that Apelin has a statistically significant correlation with BMI, FBS, fasting insulin, OGTT-1 and 2 hours, and HbA1c, with r = (0.34, 0.71, 0.65, 0.72, and 0.63) and P < 0.0001. ANOVA confirmed an insignificant effect of BMI centile on serum apelin, P < 0.072. ROC estimated the apelin cut-off at > 11.3 (ng/l), associated with 84% sensitivity and 100% specificity, P < 0.001.
Conclusion: Strong and significant apelin correlations with parameters for screening GDM make it a valuable marker, especially when its levels are unaffected by body mass index. Further studies are recommended to unveil therapeutic avenues for apelin.
Graphical Abstract
[1]
Taheri, M.; Irandost, K.; Mirmoezzi, M. Effect of aerobic exercise and omega-3 supplementation on psychological aspects and sleep quality in prediabetes elderly women. Sleep Hypn., 2019, 21(2), 170-174.
[2]
Golbar, S.J.; Gharekhanlu, R.; Kordi, M.R.; Khazani, A. Effects of endurance exercise training on kinesin - 5 and dynein motor proteins in sciatic nerves of male wistar rats with diabetic neuropathy. Int. J. Sport. Stud. Health., 2018, e67758.
[http://dx.doi.org/10.5812/intjssh.67758]
[http://dx.doi.org/10.5812/intjssh.67758]
[3]
Alexopoulos, A.S.; Blair, R.; Peters, A.L. Management of preexisting diabetes in pregnancy. JAMA, 2019, 321(18), 1811-1819.
[http://dx.doi.org/10.1001/jama.2019.4981] [PMID: 31087027]
[http://dx.doi.org/10.1001/jama.2019.4981] [PMID: 31087027]
[4]
Saeidi, A.; Hackney, A.C.; Tayebi, S.M.; Ahmadian, M.; Zouhal, H. Diabetes, insulin resistance, fetuin-B and exercise training. Ann. Appl. Sport Sci., 2019, 7(2), 1-2.
[http://dx.doi.org/10.29252/aassjournal.7.2.1] [PMID: 31321377]
[http://dx.doi.org/10.29252/aassjournal.7.2.1] [PMID: 31321377]
[5]
Plows, J.; Stanley, J.; Baker, P.; Reynolds, C.; Vickers, M. The pathophysiology of gestational diabetes mellitus. Int. J. Mol. Sci., 2018, 19(11), 3342.
[http://dx.doi.org/10.3390/ijms19113342] [PMID: 30373146]
[http://dx.doi.org/10.3390/ijms19113342] [PMID: 30373146]
[6]
Petersen, M.C.; Shulman, G.I. Mechanisms of insulin action and insulin resistance. Physiol. Rev., 2018, 98(4), 2133-2223.
[http://dx.doi.org/10.1152/physrev.00063.2017] [PMID: 30067154]
[http://dx.doi.org/10.1152/physrev.00063.2017] [PMID: 30067154]
[7]
Roomi, A.B.; Nori, W.; Al-Badry, S.H. The value of serum adiponectin in osteoporotic women: Does weight have an effect? J. Obes., 2021, 2021, 1-5.
[http://dx.doi.org/10.1155/2021/5325813] [PMID: 34796028]
[http://dx.doi.org/10.1155/2021/5325813] [PMID: 34796028]
[8]
Salzer, L.; Tenenbaum-Gavish, K.; Hod, M. Metabolic disorder of pregnancy (understanding pathophysiology of diabetes and preeclampsia). Best Pract. Res. Clin. Obstet. Gynaecol., 2015, 29(3), 328-338.
[http://dx.doi.org/10.1016/j.bpobgyn.2014.09.008] [PMID: 25481558]
[http://dx.doi.org/10.1016/j.bpobgyn.2014.09.008] [PMID: 25481558]
[9]
Nori, W.; Hamed, R.M.; Roomi, A.B. Alpha-1antitrypsin in pre-eclampsia; From a clinical perspective. J. Pak. Med. Assoc., 2021, 71(Suppl. 8), S53-S56.
[10]
Sundholm, J.K.M.; Litwin, L.; Rönö, K.; Koivusalo, S.B.; Eriksson, J.G.; Sarkola, T. Maternal obesity and gestational diabetes: Impact on arterial wall layer thickness and stiffness in early childhood - RADIEL study six-year follow-up. Atherosclerosis, 2019, 284, 237-244.
[http://dx.doi.org/10.1016/j.atherosclerosis.2019.01.037] [PMID: 30819513]
[http://dx.doi.org/10.1016/j.atherosclerosis.2019.01.037] [PMID: 30819513]
[11]
Farahvar, S.; Walfisch, A.; Sheiner, E. Gestational diabetes risk factors and long-term consequences for both mother and offspring: A literature review. Expert Rev. Endocrinol. Metab., 2019, 14(1), 63-74.
[http://dx.doi.org/10.1080/17446651.2018.1476135] [PMID: 30063409]
[http://dx.doi.org/10.1080/17446651.2018.1476135] [PMID: 30063409]
[12]
Eberlé, D.; Marousez, L.; Hanssens, S.; Knauf, C.; Breton, C.; Deruelle, P.; Lesage, J. Elabela and Apelin actions in healthy and pathological pregnancies. Cytokine Growth Factor Rev., 2019, 46, 45-53.
[http://dx.doi.org/10.1016/j.cytogfr.2019.03.003] [PMID: 30910349]
[http://dx.doi.org/10.1016/j.cytogfr.2019.03.003] [PMID: 30910349]
[13]
Wysocka, M.B.; Pietraszek-Gremplewicz, K.; Nowak, D. The role of apelin in cardiovascular diseases, obesity and cancer. Front. Physiol., 2018, 9, 557.
[http://dx.doi.org/10.3389/fphys.2018.00557] [PMID: 29875677]
[http://dx.doi.org/10.3389/fphys.2018.00557] [PMID: 29875677]
[14]
Al-Kuraishy, H.; Al-Gareeb, A.; Waheed, H.; Al-Maiahy, T. Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice. J. Adv. Pharm. Technol. Res., 2018, 9(3), 80-86.
[http://dx.doi.org/10.4103/japtr.JAPTR_273_18] [PMID: 30338233]
[http://dx.doi.org/10.4103/japtr.JAPTR_273_18] [PMID: 30338233]
[15]
Bellos, I.; Fitrou, G.; Pergialiotis, V.; Perrea, D.N.; Daskalakis, G. Serum levels of adipokines in gestational diabetes: A systematic review. J. Endocrinol. Invest., 2019, 42(6), 621-631.
[http://dx.doi.org/10.1007/s40618-018-0973-2] [PMID: 30392100]
[http://dx.doi.org/10.1007/s40618-018-0973-2] [PMID: 30392100]
[16]
Chen, J.; Li, Z.; Zhao, Q.; Chen, L. Roles of apelin/APJ system in cancer: Biomarker, predictor, and emerging therapeutic target. J. Cell. Physiol., 2022, 237(10), 3734-3751.
[http://dx.doi.org/10.1002/jcp.30845] [PMID: 35933701]
[http://dx.doi.org/10.1002/jcp.30845] [PMID: 35933701]
[17]
Duran, A.; Sáenz, S.; Torrejón, M.J.; Bordiú, E.; del Valle, L.; Galindo, M.; Perez, N.; Herraiz, M.A.; Izquierdo, N.; Rubio, M.A.; Runkle, I.; Pérez-Ferre, N.; Cusihuallpa, I.; Jiménez, S.; García de la Torre, N.; Fernández, M.D.; Montañez, C.; Familiar, C.; Calle-Pascual, A.L. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: The St. Carlos Gestational Diabetes Study. Diabetes Care, 2014, 37(9), 2442-2450.
[http://dx.doi.org/10.2337/dc14-0179] [PMID: 24947793]
[http://dx.doi.org/10.2337/dc14-0179] [PMID: 24947793]
[18]
Guo, Y.Y.; Li, T.; Liu, H.; Tang, L.; Li, Y.C.; Hu, H.T.; Su, Y.F.; Lin, Y.; Wang, Y.Y.; Li, C.; Huang, H.F.; Jin, L.; Liu, X.M. Circulating levels of elabela and apelin in the second and third trimesters of pregnancies with gestational diabetes mellitus. Gynecol. Endocrinol., 2020, 36(10), 890-894.
[http://dx.doi.org/10.1080/09513590.2020.1739264] [PMID: 32208782]
[http://dx.doi.org/10.1080/09513590.2020.1739264] [PMID: 32208782]
[19]
Aslan, M.; Celik, O.; Celik, N.; Turkcuoglu, I.; Yilmaz, E.; Karaer, A.; Simsek, Y.; Celik, E.; Aydin, S. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine, 2012, 41(3), 424-429.
[http://dx.doi.org/10.1007/s12020-011-9577-8] [PMID: 22203468]
[http://dx.doi.org/10.1007/s12020-011-9577-8] [PMID: 22203468]
[20]
Kiyak Caglayan, E.; Engin-Ustun, Y.; Sari, N.; Gocmen, A.Y.; Polat, M.F. The effects of prolonged fasting on the levels of adiponectin, leptin, apelin, and omentin in pregnant women. J. Obstet. Gynaecol., 2016, 36(4), 555-558.
[http://dx.doi.org/10.3109/01443615.2015.1103716] [PMID: 26759187]
[http://dx.doi.org/10.3109/01443615.2015.1103716] [PMID: 26759187]
[21]
Castan-Laurell, I.; Vítkova, M.; Daviaud, D.; Dray, C.; Kováčiková, M.; Kovacova, Z.; Hejnova, J.; Stich, V.; Valet, P. Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. Eur. J. Endocrinol., 2008, 158(6), 905-910.
[http://dx.doi.org/10.1530/EJE-08-0039] [PMID: 18390990]
[http://dx.doi.org/10.1530/EJE-08-0039] [PMID: 18390990]
[22]
Layton, J.; Powe, C.; Allard, C.; Battista, M.C.; Doyon, M.; Bouchard, L.; Perron, P.; Wessel, J.; Hivert, M.F. Maternal lipid profile differs by gestational diabetes physiologic subtype. Metabolism, 2019, 91, 39-42.
[http://dx.doi.org/10.1016/j.metabol.2018.11.008] [PMID: 30468781]
[http://dx.doi.org/10.1016/j.metabol.2018.11.008] [PMID: 30468781]
[23]
O’Harte, F.P.M.; Parthsarathy, V.; Hogg, C.; Flatt, P.R. Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice. PLoS One, 2018, 13(8), e0202350.
[http://dx.doi.org/10.1371/journal.pone.0202350] [PMID: 30157220]
[http://dx.doi.org/10.1371/journal.pone.0202350] [PMID: 30157220]
[24]
Soriguer, F.; Garrido-Sanchez, L.; Garcia-Serrano, S.; Garcia-Almeida, J.M.; Garcia-Arnes, J.; Tinahones, F.J.; Garcia-Fuentes, E. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes. Surg., 2009, 19(11), 1574-1580.
[http://dx.doi.org/10.1007/s11695-009-9955-y] [PMID: 19756893]
[http://dx.doi.org/10.1007/s11695-009-9955-y] [PMID: 19756893]
[25]
Ali, A.I.; Hassan, W.N.M.; Alrawi, S. A copeptin as a predictor marker for insulin resistance among women with polycystic ovary syndrome. Curr. Womens Health Rev., 2022, 18(4), e081221198670.
[http://dx.doi.org/10.2174/1573404817666211208152049]
[http://dx.doi.org/10.2174/1573404817666211208152049]
[26]
Liu, Q.; Jiang, J.; Shi, Y.; Mo, Z.; Li, M. Apelin/apelin receptor: A new therapeutic target in polycystic ovary syndrome. Life Sci., 2020, 260, 118310.
[http://dx.doi.org/10.1016/j.lfs.2020.118310] [PMID: 32835696]
[http://dx.doi.org/10.1016/j.lfs.2020.118310] [PMID: 32835696]
[27]
Mierzyński, R.; Poniedziałek-Czajkowska, E.; Dłuski, D.; Kamiński, M.; Mierzyńska, A.; Leszczyńska-Gorzelak, B. The potential role of chemerin, lipocalin 2, and apelin in the diagnosis and pathophysiology of gestational diabetes mellitus. J. Diabetes Res., 2021, 2021, 5547228.
[http://dx.doi.org/10.1155/2021/5547228] [PMID: 34212049]
[http://dx.doi.org/10.1155/2021/5547228] [PMID: 34212049]
[28]
Kourtis, A.; Gkiomisi, A.; Mouzaki, M.; Makedou, K.; Anastasilakis, A.D.; Toulis, K.A.; Gerou, S.; Gavana, E.; Agorastos, T. Apelin levels in normal pregnancy. Clin. Endocrinol., 2011, 75(3), 367-371.
[http://dx.doi.org/10.1111/j.1365-2265.2011.04061.x] [PMID: 21521329]
[http://dx.doi.org/10.1111/j.1365-2265.2011.04061.x] [PMID: 21521329]
[29]
Sun, J.; Ren, J.; Zuo, C.; Deng, D.; Pan, F.; Chen, R.; Zhu, J.; Chen, C.; Ye, S. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: A systematic review and meta-analysis. Lipids Health Dis., 2020, 19(1), 26.
[http://dx.doi.org/10.1186/s12944-020-01209-7] [PMID: 32087711]
[http://dx.doi.org/10.1186/s12944-020-01209-7] [PMID: 32087711]
[30]
de Gennaro, G.; Palla, G.; Battini, L.; Simoncini, T.; Del Prato, S.; Bertolotto, A.; Bianchi, C. The role of adipokines in the pathogenesis of gestational diabetes mellitus. Gynecol. Endocrinol., 2019, 35(9), 737-751.
[http://dx.doi.org/10.1080/09513590.2019.1597346] [PMID: 30990092]
[http://dx.doi.org/10.1080/09513590.2019.1597346] [PMID: 30990092]
[31]
Dray, C.; Knauf, C.; Daviaud, D.; Waget, A.; Boucher, J.; Buléon, M.; Cani, P.D.; Attané, C.; Guigné, C.; Carpéné, C.; Burcelin, R.; Castan-Laurell, I.; Valet, P. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab., 2008, 8(5), 437-445.
[http://dx.doi.org/10.1016/j.cmet.2008.10.003] [PMID: 19046574]
[http://dx.doi.org/10.1016/j.cmet.2008.10.003] [PMID: 19046574]
[32]
Castan-laurell, I.; Dray, C.; Knauf, C.; Kunduzova, O.; Valet, P. Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol. Metab., 2012, 23(5), 234-241.
[http://dx.doi.org/10.1016/j.tem.2012.02.005] [PMID: 22445464]
[http://dx.doi.org/10.1016/j.tem.2012.02.005] [PMID: 22445464]
[33]
Dawid, M.; Mlyczyńska, E.; Jurek, M.; Respekta, N.; Pich, K.; Kurowska, P.; Gieras, W.; Milewicz, T.; Kotula-Balak, M.; Rak, A. Apelin, APJ, and ELABELA: Role in placental function, pregnancy, and foetal development-an overview. Cells, 2021, 11(1), 99.
[http://dx.doi.org/10.3390/cells11010099] [PMID: 35011661]
[http://dx.doi.org/10.3390/cells11010099] [PMID: 35011661]
[34]
Bezerra Espinola, M.S.; Laganà, A.S.; Bilotta, G.; Gullo, G.; Aragona, C.; Unfer, V. D-chiro-inositol induces ovulation in non-polycystic ovary syndrome (PCOS), non-insulin-resistant young women, likely by modulating aromatase expression: A report of 2 cases. Am. J. Case Rep., 2021, 22, e932722.
[http://dx.doi.org/10.12659/AJCR.932722] [PMID: 34615846]
[http://dx.doi.org/10.12659/AJCR.932722] [PMID: 34615846]
[35]
D’Anna, R.; Santamaria, A.; Giorgianni, G.; Vaiarelli, A.; Gullo, G.; Di Bari, F.; Benvenga, S. Myo-inositol and melatonin in the menopausal transition. Gynecol. Endocrinol., 2017, 33(4), 279-282.
[http://dx.doi.org/10.1080/09513590.2016.1254613] [PMID: 27910708]
[http://dx.doi.org/10.1080/09513590.2016.1254613] [PMID: 27910708]
[36]
Goudakou, M.; Kalogeraki, A.; Matalliotakis, I.; Panagiotidis, Y.; Gullo, G.; Prapas, Y. Cryptic sperm defects may be the cause for total fertilization failure in oocyte donor cycles. Reprod. Biomed. Online, 2012, 24(2), 148-152.
[http://dx.doi.org/10.1016/j.rbmo.2011.10.011] [PMID: 22197604]
[http://dx.doi.org/10.1016/j.rbmo.2011.10.011] [PMID: 22197604]
[37]
Prapas, Y.; Petousis, S.; Panagiotidis, Y.; Gullo, G.; Kasapi, L.; Papadeothodorou, A.; Prapas, N. Injection of embryo culture supernatant to the endometrial cavity does not affect outcomes in IVF/ICSI or oocyte donation cycles: a randomized clinical trial. Eur. J. Obstet. Gynecol. Reprod. Biol., 2012, 162(2), 169-173.
[http://dx.doi.org/10.1016/j.ejogrb.2012.03.003] [PMID: 22464209]
[http://dx.doi.org/10.1016/j.ejogrb.2012.03.003] [PMID: 22464209]
